Towards a point-of-care test for active tuberculosis: obstacles and opportunities
- 16 February 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Microbiology
- Vol. 9 (3), 204-213
- https://doi.org/10.1038/nrmicro2521
Abstract
Limited access to diagnostic services and the poor performance of current tests result in a failure to detect millions of tuberculosis cases each year. An accurate test that could be used at the point of care to allow faster initiation of treatment would decrease death rates and could reduce disease transmission. Previous attempts to develop such a test have failed, and success will require the marriage of biomarkers that are highly predictive for the disease with innovative technology that is reliable and affordable. Here, we review the status of research into point-of-care tests for active tuberculosis and discuss barriers to the development of such diagnostic tests.Keywords
This publication has 90 references indexed in Scilit:
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Dynamic antibody responses to the Mycobacterium tuberculosis proteomeProceedings of the National Academy of Sciences, 2010
- Breath biomarkers of active pulmonary tuberculosisTuberculosis, 2010
- Rate and Amplification of Drug Resistance among Previously‐Treated Patients with Tuberculosis in Kampala, UgandaClinical Infectious Diseases, 2008
- Towards non- and minimally instrumented, microfluidics-based diagnostic devicesLab on a Chip, 2008
- Chip–NMR biosensor for detection and molecular analysis of cellsNature Medicine, 2008
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- Reducing the global burden of tuberculosis: the contribution of improved diagnosticsNature, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001